- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Vitrolife AB (VITR)
Vitrolife AB stock price live, this page displays ST VITR stock exchange data. View the VITR premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Vitrolife AB real time stock price chart below.
What Is the Vitrolife AB Stock Price Today?
The Vitrolife AB stock price today is 104.70.
What Is the Stock Symbol for Vitrolife AB?
The stock ticker symbol for Vitrolife AB is VITR.
Is VITR the Same as $VITR?
$VITR is a common way to refer to the Vitrolife AB ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Vitrolife AB Trade On?
Vitrolife AB is listed and trades on the Stockholm stock exchange.
Is Vitrolife AB a Good Stock to Buy?
Determining whether Vitrolife AB—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Vitrolife AB share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the VITR quote. (ISIN: SE0011205202)
What Is the Vitrolife AB Stock Price Today?
The Vitrolife AB stock price today is 104.70.
What Is the Stock Symbol for Vitrolife AB?
The stock ticker symbol for Vitrolife AB is VITR.
Is VITR the Same as $VITR?
$VITR is a common way to refer to the Vitrolife AB ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Vitrolife AB Trade On?
Vitrolife AB is listed and trades on the Stockholm stock exchange.
Is Vitrolife AB a Good Stock to Buy?
Determining whether Vitrolife AB—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Vitrolife AB share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the VITR quote. (ISIN: SE0011205202)
Currency in SEK
104.70
+0.40(+0.38%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
103.30
105.20
52 wk Range
84.60
163.10
VITR is included in our AI-picked strategies. See how they work
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
103.30105.20
52 wk Range
84.60163.10
Key Statistics
Edit
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.97%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.97%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
VITR Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Strong Buy
Price Target
162.67
Upside
+55.36%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Analyst Ratings
4 Buy
1 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 162.67
(+55.36% Upside)
Vitrolife AB Earnings Call Summary for Q3/2025
- Vitrolife reported 5% organic sales growth to SEK 835 million in Q3 2025, with gross margin improving to 58.9% and EBITDA reaching SEK 253 million
- Stock rose 0.48% pre-market; company trades below Fair Value per InvestingPro analysis, suggesting potential upside
- Strong performance in Americas and EMEA offset challenges in APAC; focus on innovation and IT investments bolstered competitive edge
- Management cautiously optimistic about market recovery, particularly in U.S. fertility sector; monitoring impact of U.S. presidential IVF announcement
- Analysts maintain Buy rating; company faces risks in APAC sales, macroeconomic pressures, and potential regulatory changes
Last Updated: 10/23/2025, 05:24 AM
Read Full TranscriptVitrolife investor slides for Q3/2025
Last Update: Oct 23, 2025
See full investor slides
Earnings
Latest Release
Apr 23, 2026
EPS / Forecast
0.74 / 0.77
Revenue / Forecast
807M / 810.01M
Compare VITR to Peers and Sector
Metrics to compare | VITR | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipVITRPeersSector | |
|---|---|---|---|---|
P/E Ratio | −2.8x | 18.0x | −0.5x | |
PEG Ratio | 0.00 | −0.08 | 0.00 | |
Price / Book | 1.8x | 2.4x | 2.6x | |
Price / LTM Sales | 4.1x | 3.8x | 3.2x | |
Upside (Analyst Target) | 46.2% | 86.3% | 50.8% | |
Fair Value Upside | Unlock | 6.5% | 7.7% | Unlock |
Vitrolife AB (publ) provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas. It offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. The company also provides eWitness and Labware products, such as dishes, pipettes, tubes, and VitroTemp. The company was incorporated in 1989 and is based in Gothenburg, Sweden.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Vitrolife (VITR) Stock Price Today?
The Vitrolife stock price today is 104.70 SEK.
What Stock Exchange Does Vitrolife Trade On?
Vitrolife is listed and trades on the Stockholm Stock Exchange.
What Is the Stock Symbol for Vitrolife?
The stock symbol for Vitrolife is "VITR."
Does Vitrolife Pay Dividends? What’s The Current Dividend Yield?
The Vitrolife dividend yield is 0.97%.
What Is the Vitrolife Market Cap?
As of today, Vitrolife market cap is 14.17B SEK.
What Is Vitrolife's Earnings Per Share (TTM)?
The Vitrolife EPS (TTM) is -37.01.
When Is the Next Vitrolife Earnings Date?
Vitrolife will release its next earnings report on Jul 16, 2026.
From a Technical Analysis Perspective, Is VITR a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
How Many Times Has Vitrolife Stock Split?
Vitrolife has split 1 times.
How Many Employees Does Vitrolife Have?
Vitrolife has 1126 employees.
What is the current trading status of Vitrolife (VITR)?
As of Apr 30, 2026, Vitrolife (VITR) is trading at a price of 104.70 SEK, with a previous close of 104.30 SEK. The stock has fluctuated within a day range of 103.30 SEK to 105.20 SEK, while its 52-week range spans from 84.60 SEK to 163.10 SEK.
What Is Vitrolife (VITR) Price Target According to Analysts?
The average 12-month price target for Vitrolife is 162.67 SEK, with a high estimate of 215 SEK and a low estimate of 115 SEK. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +55.36% Upside potential.
Industry Spotlight
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.